No votes yet

2015 Annual Meeting: Skin Diseases On Demand

Course description

You can earn up to 10.25 AMA PRA Category 1 Credit(s). This activity has also been designated by the ABAI for 3.5 MOC Part II Self-Assessment credits. Cost: $205 $99 for College Members, $305 $150 for non-members.

This package of courses includes the following skin disease related sessions from the 2015 ACAAI Annual Meeting in San Antonio:

  • Controversial Manifestations of Contact Dermatitis
  • Triumvirate of Parameters for Allergic Skin Diseases
  • Hereditary Angioedema: Management Challenges
  • W11 Atopic Dermatitis In-Depth
  • W19 Living With an Itch: A Practical Approach to Diagnosis and Treatment

Release Date: 12/15/2015
Expiration Date: 12/14/2018


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 10.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning objectives: 

• Discuss the relationship between metal hypersensitivity and prosthetic joint failure
• Discuss similarities and differences in allergic reactions to cardiovascular, dental and gynecologic medical devices
• Identify other causes of dermatitis with generalized distribution such  as systemic contact dermatitis to drug, food and fragrances

• Describe important identifiable causes of chronic urticaria that warrant further diagnostic work-up and discuss evidence basis for, and appropriate uses of, anti-IgE therapy for idiopathic chronic urticaria
• Discuss Practice Parameter summary statements regarding the management of refractory atopic dermatitis
• Describe proper use of patch testing and implications for management

• Recognize the clinical presentations of HAE and how to distinguish it from histamine mediated angioedema
• Appropriately determine in whom to prescribe phophylactic HAE therapy 
• Discuss the risks, benefits, and costs of available HAE treatments

• Identify common and uncommon causes of severe eczema and describe the rationale for an extended therapeutic ladder for patients refractory to standard treatments with special emphasis on compliance

• Discuss the causes of pruritus, with (including atopic dermatitis) or without a rash and the workup to seek underlying diseases; and recognize that pruritus has numerous pathways and available therapies to address itch in patients with both idiopathic pruritus and pruritus secondary to another disease 

  • 10.25 AMA PRA Category 1 Credit™
  • 10.25 Attendance
  • 3.50 MOC
Additional information

Luz S. Fonacier, MD, FACAAI -- Speaker: Baxter; Supported/Contracted Research: Baxter, Genentech, Merck

Stephen A. Tilles, MD, FACAAI -- Supported/Contracted Research: Amgen, Astellas, AstraZeneca, Biota, Circassia, DBV Technologies, Genentech, Merck, Mylan, Novartis, Perrigo, Teva

David M. Lang, MD, FACAAI -- Consultant/Advisor: Genentech, GlaxoSmithKline, Meda, Merck; Speaker: Genentech; Supported/Contracted Research: Genentech, Merck 

Mark Boguniewicz, MD, FACAAI -- Consultant/Advisor: Celgene, Regeneron; Supported/Contracted Research: Anacor

Luz S. Fonacier, MD, FACAAI -- Speaker: Baxter; Supported/Contracted Research: Baxter, Genentech, Merck

Richard G. Gower, MD, FACAAI -- Consultant/Advisor: CSL Behring, Dyax, HollisterStier, Mylan, Shire, Teva; Speaker: CSL Behring, Mylan, Shire, Teva; Supported/Contracted Research: Anacor, Biocryst, Circassia, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan, Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck 

Marc A. Riedl, MD, MS -- Consultant/Advisor: Baxter, BioCryst, CSL Behring, Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax, Salix, Shire: Supported/Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Shire 

Bruce L. Zuraw, MD, FACAAI -- Consultant/Advisor: BioCryst, CSL Behring, Dyax, Genentech, Isis, Novartis, Sanofi, Shire

Peter A. Lio, MD -- Consultant/Advisor: Anacor, Galderma, Johnson & Johnson, Pierre Fabre, Valeant 

The following have no financial relationships to disclose:

Peter Schalock, MD

James S. Taylor, MD, FACAAI

David E. Cohen, MD

Course summary
Available credit: 
  • 10.25 AMA PRA Category 1 Credit™
  • 10.25 Attendance
  • 3.50 MOC
Course opens: 
Course expires: 
Please login or create an account to take this course.

Payment required

You must purchase this course.